PATENT CLAIM ANALYSIS

Application Number: 15961002
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2019-03
Patent Classification: ["514", "230500"]

Abstract:
Methods of treating developmental disorders and/or seizure disorders with etifoxine, a deuterated analog of etifoxine, or a pharmaceutically acceptable salt, solvate, or prodrug thereof are provided. The methods provide therapeutic compositions that may be used to improve one or more symptoms of the developmental disorder and/or seizure disorder.

Claim (Index 5):
The method of  claim 1 , wherein the etifoxine comprises S-etifoxine or a pharmaceutically acceptable salt thereof.

Metadata:
- Claim Count in Document: 3.0
- Percentile: 91.0
- Lexical Diversity: 1.38462
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15680417', '15191068', '14876110', '15493374', '15904901']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7857851773567154
- 35 USC 102 Novelty (BERT): 0.5326438360533139
- Combined Prediction Score: 0.7604710432263753
- Mean Citation Score: 289.026612
- Max Citation Score: 344.95847000000015
- Similarity Product: 213.6310149116922

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test